Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine

Stock Information for Spectral Medical Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Spectral Medical Inc

Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update
Spectral Medical Provides Update on PMA Submission Timing for PMX-20R
Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF
Spectral Medical Announces Publication of EDEN Observational Study
Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 - 9, 2025
Spectral Medical Receives US$3 Million From Vantive
Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.